Cyclopharm Limited (ASX: CYC)

Cyclopharm Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	236	181	109	153	201	92
Market Cap Growth	0.12%	66.37%	-28.90%	-23.69%	117.38%	21.62%
Enterprise Value	212	167	87	126	197	93
Last Close Price	2.12	1.93	1.16	1.62	2.46	1.15
Forward PE	-	-	-	-	171.49	-
PS Ratio	8.35	6.67	4.38	7.66	11.35	5.43
PB Ratio	4.96	5.61	2.98	3.56	11.73	3.98
P/TBV Ratio	4.49	6.63	3.41	3.98	15.91	4.90
EV/Sales Ratio	8.82	6.16	3.49	6.31	11.17	5.45
EV/FCF Ratio	-16.72	-	-	-	-	-
Debt / Equity Ratio	0.12	0.13	0.12	0.10	0.27	0.21
Asset Turnover	0.42	0.57	0.47	0.48	0.58	0.61
Inventory Turnover	1.11	1.11	1.08	0.98	1.10	1.10
Quick Ratio	3.34	2.26	3.53	5.03	1.93	4.85
Current Ratio	4.38	3.48	4.65	5.83	2.81	5.64
Return on Equity (ROE)	-22.59%	-13.67%	-16.61%	-16.75%	-29.98%	-14.48%
Return on Assets (ROA)	-15.37%	-12.08%	-7.12%	-6.93%	-11.27%	-8.11%
Return on Capital (ROIC)	-18.88%	-14.91%	-8.48%	-8.40%	-13.72%	-10.05%
Earnings Yield	-4.64%	-2.60%	-6.07%	-3.29%	-3.01%	-3.15%
FCF Yield	-5.39%	-4.10%	-7.29%	-1.61%	-4.55%	-0.57%
Dividend Yield	0.00%	0.26%	0.86%	0.62%	0.41%	0.87%
Buyback Yield / Dilution	-2.93%	-0.53%	-2.77%	-17.10%	-12.43%	-0.22%
Total Shareholder Return	-2.93%	-0.27%	-1.92%	-16.49%	-12.03%	0.65%

Source: S&P Capital IQ. Standard template. Financial Sources.